Tarik Asselah, MD, PhD, professor of hepatology at Hôpital Beaujon and the University of Paris-Cité, highlighted alcohol-related liver disease and rare liver conditions as chronically underfunded ...

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the best high short interest stocks with highest upside potential.

Mirum Pharmaceuticals Inc. (NASDAQ:MIRM) is one of the best high short interest stocks with highest upside potential.

EIT Pharma presented new analyses from the lonafarnib development program for Chronic Hepatitis Delta (CHD) at EASL Congress ...

With a historic WHO resolution adopted this week giving countries, for the first time, a mandate to address liver disease ...

Tune Therapeutics, a leading epigenome editing company, presented new data today at the European Association for the Study of ...

Alcohol policy and liver disease were central at this EASL 2026 session. Experts called for stronger labelling and prevention ...

Data from the NAVIGATE trial presented at EASL 2026 (May 27–30, Barcelona) oral presentation demonstrates belapectin reduces varices development ...

Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that new 48-week data from the IMPACT Phase 2b ...

Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...

Supplement-induced liver injury is rising as wellness supplement use grows globally. Learn more about the risks highlighted at EASL 2026.

RTY-406 demonstrates significant improvements in disease relevant endpoints in a mouse model of primary sclerosing cholangitis (PSC) and proof of mechanism in non-human primates ...